摘要
目的:观察和血明目片对视网膜静脉阻塞所致眼底出血的临床疗效。方法:将视网膜静脉阻塞所致眼底出血的患者78例82眼随机分为治疗组38例40眼、对照组40例42眼,治疗组患者服用和血明目片进行治疗,对照组患者服用VC、芦丁以及阿司匹林进行治疗,共分为2个疗程。结果:治疗组患者视网膜出血显著吸收,疗效明显高于对照组,差异具有统计学意义(P<0.05)。结论:和血明目片治疗视网膜静脉阻塞所致眼底出血疗效显著。
AIM：To observe the clinical efficacy of hexuemingmu tablet for retinal hemorrhage caused by retinal vein occlusion.
METHODS：Totally 78 patients 82 eyes with retinal hemorrhage caused by retinal vein occlusion were randomly divided into two groups： the treatment group（38 cases,40 eyes） and the control group（40 cases, 42 eyes）.The treatment group was given hexuemingmu tablet,the control group was given VC ,rutin and aspirin .All patients underwent the drug therapy for 2 periods.
RESULTS：Compared with the control group, retinal hemorrhage was obviously absorbed in the treatment group, and the difference was statistically significant （P〈0.01）.
CONCLUSION：Hexuemingmu tablet is an effective drug for retinal hemorrhage caused by retinal vein occlusion.
出处
《国际眼科杂志》
CAS
2010年第12期2391-2392,共2页
International Eye Science
